Roche’s subcutaneous OCREVUS one-year data demonstrates near-complete suppression of clinical relapses and brain lesions in patients with progressive and relapsing forms of MS
Results from the Phase III study showed that subcutaneous (SC) injection was consistent with IV infusion and demonstrated near-complete suppression of relapse activity (97%) and MRI lesions (97.2%) through 48 weeks The twice-yearly, 10-minute SC injection has the potential to expand the usage of OCREVUS to treatment centres without IV infrastructure or with IV capacity […]
Roche’s Columvi meets primary endpoint of overall survival in people with relapsed or refractory diffuse large B-cell lymphoma in Phase III STARGLO study
Columvi, in combination with chemotherapy, demonstrated a statistically significant improvement in overall survival for people with relapsed or refractory diffuse large B-cell lymphoma Data from the STARGLO study will be submitted to health authorities and presented at an upcoming medical meeting Basel, 15 April 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the […]
In world first, Nigeria introduces new 5-in-1 vaccine against meningitis
Health workers rollout immunization campaign aiming to reach one million In a historic move, Nigeria has become the first country in the world to roll out a new vaccine (called Men5CV) recommended by the World Health Organization (WHO), which protects people against five strains of the meningococcus bacteria. The vaccine and emergency vaccination activities are […]
Leading health agencies outline updated terminology for pathogens that transmit through the air
Following consultation with public health agencies and experts, the World Health Organization (WHO) publishes a global technical consultation report introducing updated terminology for pathogens that transmit through the air. The pathogens covered include those that cause respiratory infections, e.g. COVID-19, influenza, measles, Middle East respiratory syndrome (MERS), severe acute respiratory syndrome (SARS), and tuberculosis, among […]
Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis
The Elecsys® pTau217 plasma biomarker test is being developed as part of an ongoing partnership between Roche and Eli Lilly and Company Once approved, the test will aid healthcare providers in identifying amyloid pathology, a key feature of Alzheimer’s disease Roche and Lilly believe the test could play an important role in improving access to […]
WHO calls for action to uphold right to health amidst inaction, injustice and crises
On the anniversary of its founding, the Organization urges countries to invest, tackle discrimination and intolerance, and expand equitable access to quality health services 5 April 2024 - To mark World Health Day (7 April), the World Health Organization (WHO) is running the “My health, my right” campaign to champion the right to health of […]
Triple risk of harm for Ukraine's health transport workers over other health-care staff, WHO data indicates
Kyiv, Ukraine, 4 April 2024 - A concerning new trend has emerged from the WHO Surveillance System for Attacks on Health Care (SSA) in Ukraine: Ambulance workers and other personnel servicing health transport face a risk of injury and death 3 times higher than that of other health-care service workers. “Many emergency teams come under […]
Explainer on Ayushman Bharat Health Accounts (ABHA)
Ayushman Bharat Health Accounts (ABHA) is an integral component of the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), which is India's flagship national health protection scheme. ABHA is designed to facilitate cashless transactions and manage financial aspects related to healthcare services under the Ayushman Bharat scheme. Here's an explainer on Ayushman Bharat Health Accounts: […]
WHO Member States agree to resume negotiations aimed at finalizing the world’s first pandemic agreement
Geneva, 28 March 2024-- WHO Member States agreed to resume negotiations aimed at finalizing a pandemic agreement during 29 April to 10 May. The decision came at today’s end of two weeks of intensive country-led discussions on critical subjects aimed at making all countries of the world better prepared for, and able to effectively and […]
WHO launches CoViNet: a global network for coronaviruses
Geneva, 27 March 2024 -- WHO has launched a new network for coronaviruses, CoViNet, to facilitate and coordinate global expertise and capacities for early and accurate detection, monitoring and assessment of SARS-CoV-2, MERS-CoV and novel coronaviruses of public health importance. CoViNet expands on the WHO COVID-19 reference laboratory network established during the early days of […]
